Definium Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
NEW YORK, November 09, 2026--Definium Therapeutics, Inc. ("Definium" or the "Company") (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics…



